|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.404
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.330
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.298
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.295
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.290
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.272
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.269
|
Mouse |
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.266
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.260
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.250
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.231
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.228
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.225
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.213
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.204
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.194
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.194
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.193
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.185
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.160
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.158
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.153
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.150
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.150
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.148
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.146
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.146
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.143
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.143
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.141
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.141
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.140
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.140
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.136
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.135
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.134
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.133
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.132
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.132
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.130
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.129
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.127
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.127
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.124
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.121
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.116
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.115
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.115
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.115
|
Mouse |
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.114
|
Human |
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.114
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.114
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.113
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.113
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.110
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.110
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.110
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.107
|
Human |
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.106
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.106
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.105
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.105
|
Human |
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.105
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.105
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.105
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.105
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.104
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.104
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.102
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.102
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.102
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.102
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.101
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.101
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.100
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.100
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.099
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.098
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.098
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.097
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.095
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.095
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.094
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.093
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.092
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.092
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.091
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.090
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.090
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.089
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.088
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.088
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.087
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.087
|
|
|
|
positive regulation of podosome assembly
|
GO:0071803 |
3 |
0.086
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.084
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.084
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.084
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.083
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.082
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.082
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.082
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.082
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.081
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.081
|
Human |
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.081
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.080
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.080
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.079
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.079
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.079
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.078
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.078
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.078
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.077
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.077
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.077
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.077
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.076
|
|
|
|
lamellipodium organization
|
GO:0097581 |
29 |
0.076
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.075
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.075
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.075
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.074
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.074
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.074
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.074
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.074
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.074
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.073
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.073
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.073
|
Mouse |
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.073
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.072
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.072
|
|
|
|
morphogenesis of an epithelial sheet
|
GO:0002011 |
27 |
0.072
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.070
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.070
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.070
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.070
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.070
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.069
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.069
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.069
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.068
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.068
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.068
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.068
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.067
|
|
|
|
negative regulation of dendritic spine morphogenesis
|
GO:0061002 |
3 |
0.067
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.067
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.067
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.066
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.066
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.066
|
|
|
|
maintenance of apical basal cell polarity
|
GO:0035090 |
3 |
0.065
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.065
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.065
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.065
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.065
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.065
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.064
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.064
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.063
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.063
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.063
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.063
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.063
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.062
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.062
|
Human |
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.062
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.062
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.062
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.061
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.060
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.060
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.060
|
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.059
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.059
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.059
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.058
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.058
|
|
|
|
epiboly
|
GO:0090504 |
8 |
0.058
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.058
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.058
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.057
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.057
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.057
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.055
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.055
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.054
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.054
|
Human |
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.054
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.053
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.053
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.053
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.053
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.052
|
Human |
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.052
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.052
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
47 |
0.052
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.052
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.052
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.051
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.051
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.051
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.051
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.050
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.050
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.050
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.050
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.049
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.049
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.049
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.049
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.049
|
Mouse |
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.049
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.048
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.048
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.048
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.048
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.048
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.048
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.047
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.047
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.047
|
|
|
|
lipopolysaccharide mediated signaling pathway
|
GO:0031663 |
25 |
0.047
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.047
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.046
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.046
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.046
|
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.046
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.046
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.046
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.046
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.045
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.045
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.045
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.045
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.045
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.045
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.045
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.045
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.044
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.044
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.044
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.044
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.044
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.044
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.043
|
|
|
|
cellular glucose homeostasis
|
GO:0001678 |
52 |
0.043
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.043
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.043
|
|
|
|
negative regulation of dendritic spine development
|
GO:0061000 |
3 |
0.043
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.043
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.043
|
|
|
|
retina vasculature morphogenesis in camera type eye
|
GO:0061299 |
10 |
0.042
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.042
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.041
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.041
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.041
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.041
|
|
|
|
t cell receptor signaling pathway
|
GO:0050852 |
46 |
0.041
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.041
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.040
|
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.040
|
|
|
|
dendritic spine organization
|
GO:0097061 |
26 |
0.040
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.040
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.040
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.040
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.039
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.039
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.039
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.039
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.039
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.039
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.039
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.039
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.039
|
|
|
|
negative regulation of leukocyte proliferation
|
GO:0070664 |
46 |
0.039
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.038
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.038
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.038
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.038
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.038
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.038
|
Human |
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.038
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.038
|
|
|
|
fasciculation of sensory neuron axon
|
GO:0097155 |
3 |
0.038
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.038
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.037
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.037
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.037
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.037
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
22 |
0.037
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.037
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.036
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.036
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.036
|
|
|
|
adherens junction assembly
|
GO:0034333 |
22 |
0.036
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.036
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.036
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.036
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.036
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.036
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.035
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.035
|
Human |
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.035
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.035
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.035
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.035
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.034
|
|
|
|
regulation of exocytosis
|
GO:0017157 |
61 |
0.034
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.034
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.034
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.034
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.034
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.034
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.034
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.033
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.033
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.033
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.033
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.033
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.033
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.033
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.032
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.032
|
Mouse |
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.032
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.032
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.032
|
|
|
|
cell substrate junction assembly
|
GO:0007044 |
24 |
0.032
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.032
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.032
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.031
|
|
|
|
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development
|
GO:0060528 |
4 |
0.031
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.031
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.031
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.031
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.031
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.031
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.031
|
|
|
|
retina vasculature development in camera type eye
|
GO:0061298 |
17 |
0.030
|
|
|
|
ephrin receptor signaling pathway
|
GO:0048013 |
20 |
0.030
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.030
|
Human |
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.030
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.030
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.030
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.030
|
|
|
|
parathyroid hormone secretion
|
GO:0035898 |
2 |
0.030
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.030
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.030
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.029
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.029
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.029
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.029
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.029
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.029
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.029
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.029
|
|
|
|
cellular response to hexose stimulus
|
GO:0071331 |
47 |
0.029
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.029
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.029
|
|
|
|
regulation of b cell proliferation
|
GO:0030888 |
39 |
0.029
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.029
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.029
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.028
|
|
|
|
dendritic spine development
|
GO:0060996 |
30 |
0.028
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.028
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.028
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.028
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.028
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.028
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.028
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.028
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.028
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.028
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.027
|
|
|
|
fasciculation of motor neuron axon
|
GO:0097156 |
2 |
0.027
|
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.027
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.027
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.027
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.027
|
|
|
|
toll like receptor signaling pathway
|
GO:0002224 |
38 |
0.027
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.027
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.027
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.027
|
Human |
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.027
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.027
|
|
|
|
regulation of dendritic spine development
|
GO:0060998 |
22 |
0.027
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.027
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.027
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.026
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.026
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.026
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.026
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.026
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.026
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.026
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.026
|
Mouse |
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.026
|
|
|
|
regulation of dendritic spine morphogenesis
|
GO:0061001 |
17 |
0.026
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.026
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.025
|
|
|
|
regulation of chorionic trophoblast cell proliferation
|
GO:1901382 |
1 |
0.025
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.025
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.025
|
|
|
|
retinal ganglion cell axon guidance
|
GO:0031290 |
18 |
0.025
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.025
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.025
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.025
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.025
|
|
|
|
axial mesoderm formation
|
GO:0048320 |
3 |
0.025
|
|
|
|
dendritic spine morphogenesis
|
GO:0060997 |
22 |
0.025
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.025
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.024
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.024
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.024
|
|
|
|
acylglycerol biosynthetic process
|
GO:0046463 |
18 |
0.024
|
|
|
|
hexose catabolic process
|
GO:0019320 |
3 |
0.024
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.024
|
|
|
|
platelet derived growth factor receptor signaling pathway
|
GO:0048008 |
32 |
0.024
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.024
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.024
|
|
|
|
positive regulation of long term neuronal synaptic plasticity
|
GO:0048170 |
3 |
0.024
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.024
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.024
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.024
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.024
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.024
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.024
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.024
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.024
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.024
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.023
|
|
|
|
regulation of insulin secretion involved in cellular response to glucose stimulus
|
GO:0061178 |
31 |
0.023
|
|
|
|
regulation of triglyceride biosynthetic process
|
GO:0010866 |
10 |
0.023
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.023
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.023
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.023
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.023
|
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.023
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.023
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.023
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.023
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.023
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.023
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.023
|
|
|
|
negative regulation of b cell proliferation
|
GO:0030889 |
13 |
0.023
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.023
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.023
|
|
|
|
negative chemotaxis
|
GO:0050919 |
14 |
0.023
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.023
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.022
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.022
|
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.022
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.022
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.022
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.022
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.022
|
|
|
|
positive regulation of neuron death
|
GO:1901216 |
28 |
0.022
|
|
|
|
establishment of protein localization to plasma membrane
|
GO:0090002 |
34 |
0.022
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.022
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
50 |
0.022
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.022
|
|
|
|
positive regulation of t cell proliferation
|
GO:0042102 |
52 |
0.022
|
|
|
|
negative regulation of t cell proliferation
|
GO:0042130 |
38 |
0.022
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.022
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.022
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.022
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.022
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.022
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.021
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.021
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.021
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.021
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.021
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.021
|
|
|
|
positive regulation of jun kinase activity
|
GO:0043507 |
30 |
0.021
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.021
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.021
|
|
|
|
erbb signaling pathway
|
GO:0038127 |
32 |
0.021
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.021
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.021
|
|
|
|
positive regulation of b cell activation
|
GO:0050871 |
49 |
0.021
|
|
|
|
oocyte development
|
GO:0048599 |
33 |
0.021
|
|
|
|
glycerophospholipid biosynthetic process
|
GO:0046474 |
32 |
0.021
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
3 |
0.021
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.021
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.021
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.021
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.020
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.020
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.020
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.020
|
|
